European Archives - Page 293 of 1317 - European Medical Journal

New Strategies for Managing Compensated Liver Disease

Non-selective β-blockers have demonstrated significant potential in preventing decompensation.

Apixaban Reduces Stroke Risk in Patients with Subclinical Atrial Fibrillation

A recent ARTESiA trial analysis suggests apixaban may reduce stroke risk in patients with subclinical atrial fibrillation and a history of stroke

Women on Menopausal Hormone Therapy Face Higher Risk of Lupus and Scleroderma

A new study suggests that menopausal hormone therapy (MHT) may increase the risk of systemic lupus erythematosus and systemic sclerosis.

The Hidden Impact of Infertility Stigma on Mental Health and Well-Being

Greater infertility stigma is linked to higher distress, while openness with others may improve well-being and meaning in life.

AI Models Predict Breast Cancer Recurrence and Metastasis with High Accuracy

AI and ML predict breast cancer recurrence and metastasis, offering new tools for better patient risk assessment and care.

New Guidelines Cut Hospital Stays for Febrile Infants

A new clinical practice guideline for well-appearing febrile infants has led to a reduction in hospitalisations, antibiotic use, and invasive procedures.

Waist Size More Closely Linked to Colorectal Cancer Risk Than BMI

A UK Biobank study has revealed that central obesity, measured by waist circumference and waist-to-hip ratio, may be a stronger predictor of colorectal cancer risk than BMI.

Surgical Outcomes in Hidradenitis Suppurativa: Impact of Comorbidities

Diabetes was investigated in five studies, with only one demonstrating a correlation between the condition and higher hospital readmission rates.

Young People with HCM at High Risk of Sudden Cardiac Death from High-Intensity Exercise

Younger patients with hypertrophic cardiomyopathy face increased sudden cardiac death risk during high-intensity exercise, despite no link to traditional risk factors.

Increased Risk of Skin Cancer After Blood or Marrow Transplant

BMT survivors face a higher risk of skin cancer, with age, graft-vs-host disease, and treatment influencing outcomes.